Ricerc@Sapienza

Abstract 19 Background : 20 HIV infection may affect cardiovascular system through different physio pathological patterns 21 including viral vasculitis, thrombophilia induction, opportunistic infection, major HIV vasculo- 22 tropic coinfections and secondary effects of antiretroviral therapy. Vessel pathology may 23 manifest as obstructive disease, dissection or aneurysm conditions that may involve major , 24 medium or small vessels, in different arterial branches.

Cardiovascular prevention represents a cornerstone of modern strategies to reduce the burden of cardiovascular disease.

Disease cardiology and cardiovascular medicine

Context Neurotensin (NT), an intestinal peptide released by fat ingestion, promotes lipid absorption; higher circulating NT levels are associated with type 2 diabetes (T2D), obesity, and cardiovascular disease. Whether NT is related to nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) has not been fully investigated. Objective To study the relationship between plasma proneurotensin 1 to 117 (pro-NT), a stable fragment of the NT precursor hormone, and the presence/severity of NAFLD/NASH and to unravel correlates of increased pro-NT levels.

BACKGROUND: Previous studies suggested obstructive sleep apnoea syndrome (OSAS) as a major risk factor for incident cardiovascular events. However, the relationship between OSAS severity, the use of continuous positive airway pressure (CPAP) treatment and the development of cardiovascular disease is still matter of debate.
STUDY OBJECTIVES: The aim was to test the association between OSAS and cardiovascular events in patients with concomitant cardio-metabolic diseases and the potential impact of CPAP therapy on cardiovascular outcomes.

Not abstract available

Intensive exercise of elite athletes can lead to physiological alterations in the cardiovascular system in response to increased stroke volume and blood pressure, known collectively as cardiovascular demand (CD). This study aimed to compare metabolic differences in elite athletes with high vs low/moderate CD and to reveal their underlying metabolic pathways as potential biomarker signatures for assessing health, performance, and recovery of elite athletes.